Sounds to me like Noxopharm has pivoted from trying to sell each "pillar" to big Pharma to entering into out-licencing partnerships instead.
Is this the first time this has been mentioned?
NOX CEO Interview on Orphan Drug Status, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $11.41K | 108.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 123424 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |